Literature DB >> 21663433

Guanfacine extended release in two patients with pervasive developmental disorders.

Kelly Blankenship, Craig A Erickson, Kimberly A Stigler, David J Posey, Christopher J McDougle.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21663433      PMCID： PMC3111864          DOI： 10.1089/cap.2010.0057

Source DB:  PubMed          Journal:  J Child Adolesc Psychopharmacol        ISSN： 1044-5463            Impact factor:   2.576


× No keyword cloud information.
  11 in total

Review 1.  Guidelines and algorithms for the use of methylphenidate in children with Attention-Deficit/ Hyperactivity Disorder.

Authors:  L Greenhill; D H Beyer; J Finkleson; D Shaffer; J Biederman; C K Conners; C Gillberg; M Huss; P Jensen; J L Kennedy; R Klein; J Rapoport; T Sagvolden; T Spencer; J M Swanson; N Volkow
Journal:  J Atten Disord       Date:  2002       Impact factor: 3.256

2.  Behavioral and emotional problems in young people with pervasive developmental disorders: relative prevalence, effects of subject characteristics, and empirical classification.

Authors:  Luc Lecavalier
Journal:  J Autism Dev Disord       Date:  2006-11

3.  Randomized, controlled, crossover trial of methylphenidate in pervasive developmental disorders with hyperactivity.

Authors: 
Journal:  Arch Gen Psychiatry       Date:  2005-11

4.  The relative sensitivity of the Clinical Global Impressions Scale and the Brief Psychiatric Rating Scale in antipsychotic drug trials.

Authors:  Stefan Leucht; Rolf R Engel
Journal:  Neuropsychopharmacology       Date:  2006-02       Impact factor: 7.853

5.  Guanfacine treatment of hyperactivity and inattention in pervasive developmental disorders: a retrospective analysis of 80 cases.

Authors:  David J Posey; Jessica I Puntney; Teresa M Sasher; Deborah L Kem; Christopher J McDougle
Journal:  J Child Adolesc Psychopharmacol       Date:  2004       Impact factor: 2.576

6.  A randomized, double-blind, placebo-controlled study of guanfacine extended release in children and adolescents with attention-deficit/hyperactivity disorder.

Authors:  Joseph Biederman; Raun D Melmed; Anil Patel; Keith McBurnett; Jennifer Konow; Andrew Lyne; Noreen Scherer
Journal:  Pediatrics       Date:  2008-01       Impact factor: 7.124

Review 7.  Guanfacine and guanfacine extended release: treatment for ADHD and related disorders.

Authors:  David J Posey; Christopher J McDougle
Journal:  CNS Drug Rev       Date:  2007

8.  Guanfacine extended release in children and adolescents with attention-deficit/hyperactivity disorder: a placebo-controlled trial.

Authors:  Floyd R Sallee; James McGough; Tim Wigal; Jessica Donahue; Andrew Lyne; Joseph Biederman
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2009-02       Impact factor: 8.829

Review 9.  Stimulant drug effects in developmental disorders and hyperactivity--toward a resolution of disparate findings.

Authors:  M G Aman
Journal:  J Autism Dev Disord       Date:  1982-12

10.  Guanfacine in children with autism and/or intellectual disabilities.

Authors:  Benjamin L Handen; Robert Sahl; Antonio Y Hardan
Journal:  J Dev Behav Pediatr       Date:  2008-08       Impact factor: 2.225
View more
  1 in total

Review 1.  Pharmacologic treatments for the behavioral symptoms associated with autism spectrum disorders across the lifespan.

Authors:  Carolyn A Doyle; Christopher J McDougle
Journal:  Dialogues Clin Neurosci       Date:  2012-09       Impact factor: 5.986
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.